Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | URI | APD |
|---|---|---|
| Price | $1,020.86 | $285.70 |
| Change today | ▼ 1.08% | ▼ 0.44% |
| Market cap | $63.54B | $63.62B |
| Return, 3 months | -5.6% | +3.1% |
| Return, year to date | +26.9% | +18.0% |
| Return, 1 year | +10.0% | +7.7% |
| P/E (TTM) | 24.6 | -1,360.5 |
| P/B | 6.9 | 4.6 |
| P/E percentile vs own 5y | 86th | 2nd |
| Dividend yield | 0.74% | 2.52% |
| Revenue growth (YoY, latest qtr) | +11.8% | +4.6% |
| Net profit growth (YoY) | +21.1% | -296.7% |
| Gross margin | 38.4% | 32.1% |
| Operating margin | 25.1% | 24.8% |
| Net margin | 15.7% | -0.4% |
| Return on equity | 28.9% | -0.3% |
| Analyst target vs. price | +26.7% | +18.9% |
| Analyst buy share | 86% | 64% |
| RSI (14) | 54 | 44 |
| 30-day volatility | 29.6% | 19.7% |
| Max drawdown, 1 year | -30.0% | -21.1% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.